About Christine Stevenson

This author has not yet filled in any details.
So far Christine Stevenson has created 33 blog entries.

Intrexon CEO RJ Kirk to Speak at SB7.0

The Seventh International Meeting on Synthetic Biology (SB7.0) is due to take place in June at the National University of Singapore, where a truly extraordinary lineup of speakers will take the stage to discuss goals and challenges faced within synthetic [...]

By | March 21st, 2017|News|

The Tools, Challenges, and Future Uses for Renewable Bio-based Materials

In synthetic biology, the term biodesign describes the many layers of the process by which new bio-based products are innovated. Not only does this process involve the design and engineering of microbes to generate valuable raw materials, but also molding [...]

By | March 14th, 2017|News|

Intrexon Environment Sector Head Thomas P. Bostick to Speak at SynBioBeta London

This year’s fast-approaching SynBioBeta London conference is slated to feature many participants with impressive accolades. But there is one particular speaker that stands out for his trifecta of professional, academic, and military accomplishments: General Thomas P. Bostick of Intrexon Corporation. [...]

By | February 28th, 2017|News|

Five Pioneering Female Leaders in Synthetic Biology

The issue of gender diversity in the workplace has taken a front-and-center standing across many industries of late, science and biotech notwithstanding. The lack of women in leadership roles within many organizations and companies is now being recognized, to a [...]

By | February 8th, 2017|News|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|

Twist Bioscience Issues Official Response to Lawsuit from Agilent Technologies

A new development has come to pass in the ongoing legal dispute between life science company Agilent Technologies and DNA synthesis startup Twist Bioscience. Back in February of 2016, Agilent filed a lawsuit against Twist alleging that the young company’s [...]

By | February 1st, 2017|DNA Synthesis, Industry Providers, News|